Enhanced patient support services improve patient persistence with multiple sclerosis treatment
نویسندگان
چکیده
منابع مشابه
Enhanced patient support services improve patient persistence with multiple sclerosis treatment
BACKGROUND Subcutaneous interferon beta-1a (sc IFN β-1a) therapy (44 µg or 22 µg, three times weekly) improves relapse rates and disability progression in patients with relapsing multiple sclerosis (MS). While early treatment with disease-modifying drugs may maximize therapeutic benefit, patients with low adherence or long treatment gaps are at increased risk of relapse. MySupport is an industr...
متن کاملInvestigating Environmental Barriers Affecting Participation in Patient With Multiple Sclerosis
Objective: The participation, Based on International Classification of Functioning, Disability And Health (ICF), is part of healthy function that leads to the development of skills and a sense of competence and confidence in them. People with multiple sclerosis experience problems in various areas of participation. Environmental factors can create serious restrictions in the level of participa...
متن کاملPPA-59496-enhanced-patient-support-services-improve-patient-persistenc; published by Dove Press
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be f...
متن کاملOrthodontic treatment for a patient with multiple sclerosis
Multiple sclerosis (MS) is a chronic, autoimmune inflammatory disorder of the central nervous system (CNS) that affects myelinated axons, destroying the myelin and damaging axons to varying degrees. The course of MS is highly varied and unpredictable. Metals used during orthodontic treatment can negatively affect imaging techniques used to diagnose and monitor the progression of MS, while medic...
متن کاملCase Report: GcMAF Treatment in a Patient with Multiple Sclerosis.
BACKGROUND/AIM Gc protein-derived macrophage-activating factor (GcMAF) has various functions as an immune modulator, such as macrophage activation, anti-angiogenic activity and anti-tumor activity. Clinical trials of second-generation GcMAF demonstrated remarkable clinical effects in several types of cancers. Thus, GcMAF-based immunotherapy has a wide application for use in the treatment of man...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Patient Preference and Adherence
سال: 2014
ISSN: 1177-889X
DOI: 10.2147/ppa.s59496